Meta-Analysis of the Association between Insulin-Like Growth Factor Binding Protein 3 Genetic Polymorphisms and Colorectal Cancer Susceptibility

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Xiang, Hao ^a   Wang, Ying ^a   Nie, Shaofa ^b  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; MOLECULAR PATHOLOGY; WILD TYPE; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; MEDLINE; META ANALYSIS; MISSENSE MUTATION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LINEAR MODELS; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBMED;

EID: 84875181053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059665     Document Type: Article

References (26)

1. Center MM, Jemal A, Ward E (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18: 1688-1694.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Bustin SA, Jenkins PJ, (2001) The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 7: 447-454.
4. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE, (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244.
5. Firth SM, Baxter RC, (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
6. Yu H, Rohan T, (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472-1489.
7. Gallagher EJ, LeRoith D, (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21: 610-618.
8. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet 363: 1346-1353.
9. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, et al. (2000) A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349.
10. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98: 2612-2615.
11. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, et al. (2001) Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86: 1274-1280.
12. Vorwerk P, Yamanaka Y, Spagnoli A, Oh Y, Rosenfeld RG, (1998) Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol Metab 83: 1392-1395.
13. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD, (2005) Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 14: 1204-1211.
14. Li L, Huang X, Huo K, (2009) IGFBP3 polymorphisms and risk of cancer: a meta-analysis. Molecular Biology Reports 37: 127-140.
15. Chen W, Wang S, Tian T, Bai J, Hu Z, et al. (2009) Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. European Journal of Human Genetics 17: 1668-1675.
16. Xiang H, Liu L, Chu G-d, Wei S, Liu J-p, et al. (2009) Association Between Two Functional Polymorphisms of Insulin-Like Growth Factor Binding Protein 3 and Colorectal Cancer Risk in a Chinese Population. Journal of Toxicology and Environmental Health, Part A 72: 706-711.
17. Feik E, Baierl A, Hieger B, Führlinger G, Pentz A, et al. (2009) Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes & Control 21: 91-97.
18. Deeks JJ, (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.
19. Little J, Ashktorab H, Nguza B, Fatemi M, Nouraie M, et al. (2011) Case-Control Study of Vitamin D, dickkopf homolog 1 (DKK1) Gene Methylation, VDR Gene Polymorphism and the Risk of Colon Adenoma in African Americans. PLoS ONE 6: e25314.
20. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
21. Le Marchand L, (2005) Association of an Exon 1 Polymorphism in the IGFBP3 Gene with Circulating IGFBP-3 Levels and Colorectal Cancer Risk: The Multiethnic Cohort Study. Cancer Epidemiology Biomarkers & Prevention 14: 1319-1321.
22. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, et al. (2004) Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13: 1206-1214.
23. Pechlivanis S, Wagner K, Changclaude J, Hoffmeister M, Brenner H, et al. (2007) Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Cancer Detection and Prevention 31: 408-416.
24. Wong HL, Koh WP, Probst-Hensch NM, Van den Berg D, Yu MC, et al. (2008) Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach. Gut 57: 1090-1096.
25. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, et al. (1994) Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158: 69-78.
26. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, et al. (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10: 377-384.